ACCELERON PHARMA INC. Payments to Acquire Marketable Securities
ACCELERON PHARMA INC. reported Payments to Acquire Marketable Securities of $407.58 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2021-11-04
- ACCELERON PHARMA INC. payments to acquire marketable securities for the quarter ending 2021-09-30 was $26.10M, a 74.71% decline year-over-year.
- ACCELERON PHARMA INC. payments to acquire marketable securities for the quarter ending 2021-06-30 was $111.33M, a 131.53% increase year-over-year.
- ACCELERON PHARMA INC. payments to acquire marketable securities for the quarter ending 2021-03-31 was $270.14M, a 2484.12% increase year-over-year.
- ACCELERON PHARMA INC. payments to acquire marketable securities for the quarter ending 2020-12-31 was $76.49M, a 376.79% increase year-over-year.
- ACCELERON PHARMA INC. payments to acquire marketable securities for fiscal 2020 was $238.23M, a 39.71% decline from fiscal 2019.
- ACCELERON PHARMA INC. payments to acquire marketable securities for fiscal 2019 was $395.14M, a 437.09% increase from fiscal 2018.
- ACCELERON PHARMA INC. payments to acquire marketable securities for fiscal 2018 was $73.57M, a 59.11% decline from fiscal 2017.
- ACCELERON PHARMA INC. payments to acquire marketable securities for fiscal 2017 was $179.94M, a 17.58% decline from fiscal 2016.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $26.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $137.44M derived: sum of 2 quarters · filed 2021-11-04 | $407.58M 10-Q · filed 2021-11-04 | $484.07M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $111.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $381.48M 10-Q · filed 2021-08-05 | $457.96M derived: sum of 3 quarters · filed 2021-08-05 | $561.17M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | $270.14M 10-Q · filed 2021-05-06 | $346.63M derived: sum of 2 quarters · filed 2021-05-06 | $449.83M derived: sum of 3 quarters · filed 2021-11-04 | $497.92M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | $76.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $179.69M derived: sum of 2 quarters · filed 2021-11-04 | $227.77M derived: sum of 3 quarters · filed 2021-11-04 | $238.23M 10-K · filed 2021-02-25 |
| 2020-09-30 | $103.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $151.29M derived: sum of 2 quarters · filed 2021-11-04 | $161.74M 10-Q · filed 2021-11-04 | $177.78M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $48.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $58.54M 10-Q · filed 2021-08-05 | $74.58M derived: sum of 3 quarters · filed 2021-08-05 | $159.76M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $10.45M 10-Q · filed 2021-05-06 | $26.50M derived: sum of 2 quarters · filed 2021-05-06 | $111.68M derived: sum of 3 quarters · filed 2021-05-06 | $189.48M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $16.04M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $101.22M derived: sum of 2 quarters · filed 2021-02-25 | $179.02M derived: sum of 3 quarters · filed 2021-02-25 | $395.14M 10-K · filed 2021-02-25 |
| 2019-09-30 | $85.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $162.98M derived: sum of 2 quarters · filed 2020-11-05 | $379.10M 10-Q · filed 2020-11-05 | $379.10M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $77.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $293.91M 10-Q · filed 2020-08-06 | $293.91M derived: sum of 3 quarters · filed 2021-02-25 | $301.37M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $216.12M 10-Q · filed 2020-05-11 | $216.12M derived: sum of 2 quarters · filed 2021-02-25 | $223.57M derived: sum of 3 quarters · filed 2021-02-25 | $253.74M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $7.46M derived: sum of 2 quarters · filed 2021-02-25 | $37.62M derived: sum of 3 quarters · filed 2021-02-25 | $73.57M 10-K · filed 2021-02-25 |
| 2018-09-30 | $7.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $37.62M derived: sum of 2 quarters · filed 2019-11-06 | $73.57M 10-Q · filed 2019-11-06 | $253.26M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $30.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $66.11M 10-Q · filed 2019-08-05 | $245.80M derived: sum of 3 quarters · filed 2020-02-27 | $245.87M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $35.95M 10-Q · filed 2019-05-09 | $215.64M derived: sum of 2 quarters · filed 2020-02-27 | $215.71M derived: sum of 3 quarters · filed 2020-02-27 | $215.66M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $179.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $179.76M derived: sum of 2 quarters · filed 2020-02-27 | $179.71M derived: sum of 3 quarters · filed 2020-02-27 | $179.94M 10-K · filed 2020-02-27 |
| 2017-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $24.00K derived: sum of 2 quarters · filed 2018-10-30 | $245.00K 10-Q · filed 2018-10-30 | $85.99M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $175.00K 10-Q · filed 2018-08-02 | $85.92M derived: sum of 3 quarters · filed 2019-02-27 | $57.69M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $221.00K 10-Q · filed 2018-05-08 | $85.97M derived: sum of 2 quarters · filed 2019-02-27 | $57.74M derived: sum of 3 quarters · filed 2019-02-27 | $93.01M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $85.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $57.52M derived: sum of 2 quarters · filed 2019-02-27 | $92.79M derived: sum of 3 quarters · filed 2019-02-27 | $218.31M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$28.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.04M derived: sum of 2 quarters · filed 2017-11-07 | $132.56M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $35.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $160.80M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $125.52M 10-Q · filed 2017-05-08 | |||
| 2015-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $10.11M derived: sum of 2 quarters · filed 2016-11-03 | $134.33M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $8.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $132.71M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $124.22M 10-Q · filed 2016-05-05 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | $0.00 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-07 |